Transplantation Industry

The global transplantation market size was estimated at USD 15.0 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030. Growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to the market growth. Organ failure usually occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukemia, sepsis, and other acute diseases. Demand for tissue and organ transplantation, mainly kidney, heart, liver, and lungs, is very high globally. Unhealthy dietary habits, alcohol consumption, lack of exercise, and drug abuse are some leading causes of organ failure. Thus, demand for transplantation products is expected to rise soon.

After a transplantation surgery, the recipients are prescribed powerful immunosuppressive drugs; thus, increasing their susceptibility to infectious diseases as their immunity is weakened. This can be attributed to the decline in transplantation numbers in many countries amid the COVID-19 situation. Moreover, the shortage of resources such as primary protective equipment, ICU, and blood products during the pandemic has contributed to the sharp fall in the market’s revenue in 2020.

The global increase in the demand for organs for transplant can be attributed to an increase in the incidence of acute diseases, which in turn results in an increase in the number of organ failures. For instance, diabetes and high blood pressure are the most common causes of end-stage renal disease, where kidney transplants or dialysis are the only treatment options to keep a patient alive. According to the U.S. Department of Health & Human Services, there were around 122,913 patients in the U.S. waiting to receive organs for transplant in 2019. Thus, there are high demand for advanced transplantation products for the treatment of organ failure. To manage such issues, in March 2023, U.S. government department of Health Resources and Services Administration (HRSA) took an initiative regarding transplantation network and organ procurement modernization. This idea focuses on the release of new organ donor and transplant data.

Some of the major driving factors impacting the market include the introduction of technologically advanced products and an increasing number of tissue banks. However, some of the factors such as the shortage of organ donors for transplantation procedures are expected to restrain the market growth. There is a huge gap between the demand and supply of organs for organ failure treatment.

Gather more insights about the market drivers, restrains and growth of the Global Transplantation market

Transplantation Market Segments Highlights:

• Tissue products segment was the largest revenue-generating amongst others due to escalating number of tissue and organ transplant procedures
• Tissue products segment is also expected to rise at the highest CAGR owing to advancements in transplantation products
• Tissue transplant segment held the largest revenue share in the market, because of the rising number of skin, bones, heart valves, cornea, tendons, nerves, and veins procedures worldwide
• The transplant centers segment is projected to expand at the highest CAGR during the forecast period owing to rising popularity of these centers for transplant procedures
• The hospitals segment dominated the market in terms of revenue in 2022 owing to a large number of transplant procedures performed in hospitals
• North America was the leading regional sector in 2022 and is projected to maintain its dominance during the forecast period owing to well-developed healthcare infrastructure
• Existence of a large number of research laboratories, biotechnology, and medical device companies in the North America region is the major factor contributing to its large share

Transplantation Market Report Segmentation

Grand View Research has segmented the global transplantation market on product, application, end-use, and region:

Transplantation Product Outlook (Revenue, USD Million; 2018 - 2030)

• Tissue Products
• Immunosuppressive Drugs
• Preservation Solution

Transplantation Application Outlook (Revenue, USD Million; 2018 - 2030)

• Organ Transplantation
• Tissue Transplantation

Transplantation End Use Outlook (Revenue, USD Million; 2018 - 2030)

• Hospitals
• Transplant Centers
• Others

Transplantation Regional Outlook (Revenue, USD Million; 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait

Key Companies & Market Share Insights

The market is highly fragmented with the presence of many large, small, and medium-scale vendors. The leading players in the industry are Zimmer Biomet; Medtronic; Stryker Corporation. These players are involved in launching new products, mergers & acquisitions, and regional expansion to gain maximum revenue share in the industry. Mergers and acquisitions support vendors in expanding their existing product portfolio and geographical reach. For instance, In April 2023, a team of surgeons in Spain performed world’s first robotic lung transplant, a novel lung transplant method that uses robot labelled as Da Vinci.

Rising regulatory approvals for allografts, autologous grafts, and other materials along with the development of innovative products, such as 3D bioprinting, have led to high demand for transplant products. This 3D bioprinting can be used to regenerate tissues and organs. For instance, in September 2020 Israel-based CollPlant Biotechnologies and United therapeutics announced a collaboration to include 3D bioprinting in the development of human kidneys for transplant.

Key Transplantation Company Insights

• AbbVie, Inc.
• Arthrex, Inc.
• Zimmer Biomet
• Medtronic
• Novartis AG
• Stryker
• 21st Century Medicine
• BioLifeSolutions, Inc
• Teva Pharmaceuticals
• Veloxis Pharmaceuticals

Order a free sample PDF of the Transplantation Market Intelligence Study, published by Grand View Research.